In vitro models of multiple drug resistance.
作者信息
Greenberger L M, Cohen D, Horwitz S B
机构信息
Lederle Laboratories, Department of Oncology and Tumor Immunology, Pearl River, NY 07666.
出版信息
Cancer Treat Res. 1994;73:69-106. doi: 10.1007/978-1-4615-2632-2_5.
PMID:7710911
Abstract
摘要
相似文献
1
In vitro models of multiple drug resistance.
Cancer Treat Res. 1994;73:69-106. doi: 10.1007/978-1-4615-2632-2_5.
2
Biology of the multidrug resistance-associated protein, MRP.
Eur J Cancer. 1996 Jun;32A(6):945-57. doi: 10.1016/0959-8049(96)00046-9.
3
Role of gene amplification in drug resistance.
Cancer Treat Res. 1994;73:167-200. doi: 10.1007/978-1-4615-2632-2_9.
4
The role of protein kinase C in multidrug resistance.
Cancer Treat Res. 1994;73:41-55. doi: 10.1007/978-1-4615-2632-2_3.
5
Clinical reversal of multidrug resistance.
Cancer Treat Res. 1994;73:149-65. doi: 10.1007/978-1-4615-2632-2_8.
6
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Eur J Cancer. 1996 Jun;32A(6):927-44. doi: 10.1016/0959-8049(96)00057-3.
7
Transporter molecules in multidrug resistance.
Cytotechnology. 1996;19(3):187-90. doi: 10.1007/BF00744211.
8
Unanswered questions about multidrug resistance.
Cytotechnology. 1996;19(3):177-9. doi: 10.1007/BF00744209.
9
Transcriptional regulation of multidrug resistance gene expression.
Cancer Treat Res. 1994;73:57-68. doi: 10.1007/978-1-4615-2632-2_4.
10
Multidrug resistance: genes, polymorphisms, biologic effects, reversal and treatment in cancer chemotherapy.
Anticancer Agents Med Chem. 2010 Oct 1;10(8):582. doi: 10.2174/187152010794473993.
Zotero 插件